With the FDA expecting to approve 10–20 Cell and Gene Therapies (CGTs) annually by 2025, it is evident that the field will continue to hold immense commercial and medical opportunities. To harness ...
This article explores the US and EU compliance requirements to ensure patient safety for GMP ancillary materials in cell and ...
Gene therapy is a revolutionary field in modern medicine, offering transformative potential to treat and potentially cure a wide range of genetic and acquired diseases. By addressing the root cause of ...
The "Cell Therapy Processing: Global Markets and Technologies" report has been added to ResearchAndMarkets.com's offering. The global market for cell therapy processing is estimated to grow from $2.7 ...
This story is part of a series on the current progression in Regenerative Medicine. In 1999, I defined regenerative medicine as the collection of interventions that restore tissues and organs damaged ...
First patient dosed in REVEAL pivotal trial evaluating TSHA-102 (N=15, aged 6 to <22 years) in Q4 2025, with enrollment advancing across ...
HOLLISTER, Calif., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (TKNO) (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and ...
Pharmaceutical Technology on MSN
Alternative commercialisation models offer lifeline to future of gene therapies
Nonprofit founder and CEO, Craig Martin, notes that the industry will likely see more alternative gene therapy ...
LOS ANGELES, Sept 28 (Reuters) - Student Zoe Davis, 20, was just weeks into her junior year when she landed back in the hospital with severe sickle cell pain earlier this month. She is doing what she ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback